Julia J Unternaehrer

11PUBLICATIONS
19CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 10, 2026
Interferon beta drives therapy resistance in a patient-derived model of high-grade serous ovarian cancer.

|Jun 26, 2026
Multi-Omics Analysis Reveals Chronic Cisplatin Exposure Is Associated with Metabolic Rewiring Toward Glutathione Metabolism to Support Redox Adaptation in High-Grade Serous Ovarian Cancer.

|Oct 15, 2025
The GR-LEDGF/p75-HSP27 Axis Contributes to Cross-Resistance Between Enzalutamide and Docetaxel in Prostate Cancer.

Pedro T Ochoa, Evelyn S Sanchez-Hernandez, Alfonso M Duran

|Apr 13, 2024
A Stem-like Patient-Derived Ovarian Cancer Model of Platinum Resistance Reveals Dissociation of Stemness and Resistance.

Tise Suzuki, Ashlyn Conant, Yeonkyu Jung

|Oct 14, 2023
Racial and Ethnic Disparities in Gynecologic Carcinosarcoma: A Single-Institution Experience.

Kristina E Mercado, Nora M Badiner, Canty Wang

|Aug 26, 2023
Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells.

Evelyn S Sanchez-Hernandez, Pedro T Ochoa, Tise Suzuki

Pageof 2

Frequent Collaborators

3 joint publications

Evgeny Chirshev

2 joint publications

Hanmin Wang

2 joint publications

Tise Suzuki

2 joint publications

Charles Wang